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Funding Trends
A funding profile of the NIH
Matthew Richardson

Richardson: A funding profile of the NIH

As the largest source of funding for medical
research globally (1), the National Institutes
of Health (NIH) in the United States is
responsible for distributing more than $30
billion per year to best support biomedical
researchers. According to the NIH, “[m]ore
than 83 percent [of this budget] goes to
more than 300,000 research personnel at
over 3,000 universities, medical schools, and
other research institutions in every state and
throughout the world.” (2)
In 2012, the NIH awarded 12,303 Research
Grants, including the main Research Project
Grants as well as other extramural awards
such as those specifically supporting
research centers or small businesses; in
addition, funding was awarded for training,
R&D contracts, and intramural research.
In this article we use the NIH’s publicallyreported (3,4) data to look in more detail at
the types of awards they provide, the typical
recipient of an award, and at how funding is
affecting research in specific areas.
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Types of NIH award
The most common type of award provided by
the NIH is the R01, which is one of a number
of so-called Research Project Grants (RPGs).
The R01 grant is the oldest offered by the
NIH, which is awarded “to support a discrete,
specified, circumscribed project” in an
area of the investigator’s interest (5). This is
offered alongside other RPGs such as the R15
offered to those at “educational institutions
that have not been major recipients of NIH
research grant funds” (6), and the R21 grant
which “is intended to encourage exploratory/
developmental research by providing support
for the early and conceptual stages of project
development.” (7)
In addition to RPGs, the NIH offers a variety
of awards aimed at research centers, small
businesses – including the Small Business
Innovation Research (SBIR) grant and the
Small Business Technology Transfer (STTR)
grant – Research Career Awards (the
so-called K grants), and individual and
institutional training awards.

Figure 1: Number of awards granted and success rate per grant type in 2012. Source: NIH Data Book
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Major categories of NIH award are shown
in Figure 1, p14. Award types towards the
right of the chart are those which were most
commonly awarded in 2012, with the R01 by
far the most numerous. The y-axis shows the
success rate of applicants for each award
in 2012; this varies from almost 50% for
institutional training to 14% for R21 grants.
Finally, the bubble size is proportional to the
average cost of each award in 2012; the
Research Center Awards hold the highest
cost per award, followed by the Research
Project Grants.
Profile of NIH awardees
Using the data available at the NIH Data
Book (3), we can answer many questions
about how the available budget is distributed
among investigators, and indeed students,
in biomedical fields. Here we answer three
questions concerning the profile of award
recipients: what is the representation of
women, in which fields are PhD students
supported, and how successful are first-time
investigators when applying?

Figure 2: Representation of women among research grant investigators, by type of grant. Note: 2009
and 2010 data points exclude awards made under the 2009 American Recovery and Reinvestment Act.
Source: NIH Data Book

What is the representation of women
among NIH-funded investigators?
(see Figure 2)
Mirroring the gradual dismantling of cultural
and institutional barriers preventing women
from advancing in scientific careers, NIH
grants have been increasingly awarded
to women; however the number of female
investigators is still far from reaching parity
with men, particularly in some of the types of
grant awarded.
Looking at trends from 2000 to 2012, we
can see an increase in the representation
of women in every type of research grant.
Research Project Grants (RPGs) were
awarded to female investigators in only 30%
of cases in 2012; however this does represent
an increase from 22% in 2000. The rate is
also much higher than we see for Small
Business (SBIR/STTR) and Research Center
Awards (20% in 2012).

Figure 3: Number of PhDs per field of study with NIH support prior to their PhD. Source: NIH Data Book

Research Career Awards stands above the
other types with 45% of investigators being
female in 2012, however we see no increase
in this rate since 2010.
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In which fields are NIH-supported PhDs
recipients? (see Figure 3)
The NIH supports PhD students across
numerous fields with fellowships,
traineeships, and research assistantships.
While the fields in which NIH support is
granted are those we would expect (with
Biochemistry, Health Sciences, Immunology,
Molecular Biology, and Neuroscience
featuring prominently), the long-term trends
over the past 30 years show that growth in
some areas has been much stronger than
in others. Neuroscience in particular sees
a dramatic increase to become the most
common area by a great deal, followed by
Health Sciences; another field with strong
growth, particularly in the years from 2005
to 2010, is Engineering. This makes the
current view very different from the years
1985 to 1995 when the dominant fields (as
reported by the PhD recipients themselves)
were Biochemistry, Psychology, and
Molecular Biology.

Figure 4: Success rates of applicants for R01-equivalent awards, by career stage of investigator.
Note: 2009 and 2010 data points exclude awards made under the 2009 American Recovery and
Reinvestment Act. Source: NIH Data Book

How successful are first-time investigators
vs. established investigators when applying
for NIH grants? (see Figure 4)
The overall success rate for Research
Grants has declined from a level of 33%
in 2000 to 19% in 2011 and 2012. (In the
same time period, applications for grants
increased by 72% while the number of
grants awarded, which increased steadily
until 2004, later declined until it has
returned to the same level as in 2000.)
For R01 grants, these success rates tend to
be slightly lower. But how do the success
rates differ between first-time investigators
and established investigators?
Until 2007, there was a clear (though
narrowing) gap between the success rates
of established and first-time investigators;
compare the success rates of applicants
for R01-equivalent grants in 2000, in which
29% of established investigators were
successful while the equivalent rate for
first-time investigators was 22%. In recent
years these success rates have generally
been decreasing, but first-time investigators
have received a boost in success rates
which led to parity between the two
groups in the year 2011. In 2012, we see
signs that established investigators may
once more have an advantage when
applying, with a success rate of 16% vs.
13% for first-time investigators.
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Figure 5: NIH funding per year in hypertension. Note: ‘ARRA’ in 2009 and 2010 represents funding from the
American Recovery and Reinvestment Act. Source: NIH Categorical Spending
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Research/Disease
Areas

FY 2012 Actual

CAGR 2009-12

Clinical Research

10,951

1.9%

Genetics

7,632

1.6%

Biotechnology

6,089

2.7%

Prevention

5,924

3.6%

Cancer

5,621

0.0%

Neurosciences

5,618

1.8%

Brain Disorders

3,968

3.9%

Infectious Diseases

3,867

2.2%

Table 1: Funding in 2012 per research/disease area, with Compound
Annual Growth Rate (CAGR) 2009-12. All funding values million US$.
Source: NIH Categorical Spending

Page 17

Figure 6: Article output per year in hypertension, overall (source: Scopus)
and with NIH funding (source: PubMed)

Research areas

Conclusion

References:

The Research, Condition, and Disease
Categories (RCDC) are reported by the NIH to
show funding in different areas of research
(4). We can use this information to see those
areas in which the most money is spent (see
Table 1). However, trends over time show
that the areas with highest spending have
only seen modest increases in funding since
2009: for instance, Cancer has been stable
with 0% growth. The area of Brain Disorders
has seen the highest growth out of these top
8 areas with growth of 3.9% per year.

The data made available by the NIH allows
us to look in some detail at the types of
funding provided each year and where it
is assigned. While it is of interest in its own
right, it is also a good complement to the
wider focus on tracking the impact of funded
research: see, for instance, the efforts of
FundRef (8) to enable the tracking of funded
research after the submission of papers.
Alongside the growing ability to track funded
work, we have the emergence of ORCID (9)
as a unique identifier to track authors with
confidence. As these systems are adopted
more widely, we are approaching a time
when analysis of funding, and the resulting
impact of work, can become more rigorous
and extensive.
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Of course, when we see increases in some
areas when the overall budget has remained
stable, we know that some areas must have
lost out. Hypertension is an example of an
area in which funding has reduced since
2009. The NIH Categorical Spending data
show a picture of regular declines yearon-year, which can be expected to have a
serious effect on research in this area (see
Figure 5, p.16). Using Scopus we can see
that in the same time period, the overall rate
of publication on hypertension has been
growing at 5.7% per year; PubMed can be
used to look at NIH-funded papers in the
area, and these have been growing even
more rapidly at 6.8% per year (see Figure 6).
However, this rate of growth is very unlikely
to be sustained given a scenario of reduced
funding each year from such a major
medical research funding body.
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